C.A. Stein

9.6k citations

98 papers · 7.9k indexed · 3 hit papers · h-index 45

Molecular Biology top 1%
- RNA Interference and Gene Delivery 29
- DNA and Nucleic Acid Chemistry 28
- Advanced biosensing and bioanalysis techniques 14
- Cell death mechanisms and regulation 11
- RNA and protein synthesis mechanisms 9
- CRISPR and Genetic Engineering 7
Virology top 2%
- HIV Research and Treatment 8
Cancer Research top 2%
Immunology top 5%
Oncology top 5%
Infectious Diseases
- HIV/AIDS drug development and treatment 7

Co-authors: Jack S. Cohen Nathalie Dias C. Subasinghe Kazuo Shinozuka Len Neckers Charles E. Myers S.L. Loke R. V. Larocca
Cited by: Molecular Biology Virology Cancer Research
Journals: Proceedings of the National Academy of Sciences (8 papers)Nucleic Acids Research (6 papers)Clinical Cancer Research (4 papers)
Partner nations: United States Canada Switzerland

In The Last Decade

C.A. Stein

97 papers receiving 7.6k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2002 PubMed
1989 Proceedings of the National Academy of Sciences
1988 Nucleic Acids Research

Peers

Countries citing papers authored by C.A. Stein

Since Specialization

Citations

This map shows the geographic impact of C.A. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.A. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.A. Stein more than expected).

Fields of papers citing papers by C.A. Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.A. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.A. Stein. The network helps show where C.A. Stein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C.A. Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C.A. Stein Line = papers co-authored together C.A. Stein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells Nucleic Acids Research ·Daniela Castanotto,Min Lin,Claudia Kowolik,和男深野,Xiao‐Qin Ren,Harris S. Soifer,Troels Koch,Bo R. Hansen,Henrik Oerum,Brian Armstrong,Zhigang Wang,Paul H. Bauer,John J. Rossi,C.A. Stein	2015	70
2	Defibrotide, a Polydisperse Mixture of Single-stranded Phosphodiester Oligonucleotides with Lifesaving Activity in Severe Hepatic Veno-occlusive Disease: Clinical Outcomes and Potential Mechanisms of Action Oligonucleotides ·Noah Kornblum,Kanyalakshmi Ayyanar,Luba Benimetskaya,Paul G. Richardson,Massimo Iacobelli,C.A. Stein	2006	36
3	Phosphorothioate oligonucleotides reduce mitochondrial outer membrane permeability to ADP American Journal of Physiology-Cell Physiology ·Wenzhi Tan,Johnathan C. Lai,Paul S. Miller,C.A. Stein,Marco Colombini	2006	23
4	518A2 Melanoma Cells Are Protected by G3139 and Other Antineoplastic Agents Against the Cytotoxic Effects of DTIC Oligonucleotides ·Luba Benimetskaya,Paul S. Miller,C.A. Stein	2005	4
5	The BCL2-Family of Protein Ligands as Cancer Drugs: The Next Generation of Therapeutics PubMed ·Zhengyong Han,Chen Gen-yon,Missak Haigentz,C.A. Stein,Román Pérez-Soler,Sridhar Mani	2003	37
6	Progress in the Delivery of Therapeutic Oligonucleotides: Organ/Cellular Distribution and Targeted Delivery of Oligonucleotides In Vivo Antisense and Nucleic Acid Drug Development ·Meik Führing,Washington,C.A. Stein,Richard K. Koehn,Duane E. Ruffner	2003	27
7	Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides European Journal of Pharmaceutics and Biopharmaceutics ·Nathalie Dias,C.A. Stein	2002	68
8	The experimental use of antisense oligonucleotides: a guide for the perplexed Journal of Clinical Investigation ·C.A. Stein	2001	137
9	Evidence for Higher-Order Structure Formation by the c- myb 18-mer Phosphorothioate Antisense (Codons 2-7) Oligodeoxynucleotide: Potential Relationship to Antisense c- myb Inhibition Antisense and Nucleic Acid Drug Development ·Maria Vilenchik,L. Hari Vardhan Reddy,Орымбетов Эмит Махатович,Paul S. Miller,C.A. Stein	2001	3
10	Determination of cellular internalization of fluoresceinated oligonucleotides Methods in enzymology on CD-ROM/Methods in enzymology ·Lyuba Benimetskaya,John L. Tonkinson,C.A. Stein	2000	7
11	Antisense Oligonucleotides in Cancer BioDrugs ·Irina V. Lebedeva,C.A. Stein	2000	18
12	Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization European Journal of Pharmaceutics and Biopharmaceutics ·カレルアンチェル,Lyuba Benimetskaya,Éric Allémann,C.A. Stein,Robert Gurny	1999	27
13	How to Design an Antisense Oligodeoxynucleotide Experiment: A Consensus Approach Antisense and Nucleic Acid Drug Development ·C.A. Stein	1998	44
14	Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein Nature Medicine ·Lyuba Benimetskaya,John D. Loike,Zahangir Khaled,赵洪涛,Samuel C. Silverstein,Long Cao,Daniel José Ferreira Santos,Tian‐Quan Cai,C.A. Stein	1997	203
15	Phosphorothioate oligonucleotides inhibit the replication of lentiviruses and type D retroviruses, but not that of type C retroviruses Archives of Virology ·Denis Archambault,C.A. Stein,Jack S. Cohen	1994	5
16	Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells Biochemistry ·C.A. Stein,John L. Tonkinson,Liming Zhang,L. A. Yakubov,James E. Gervasoni,Robert N. Taub,Susan A. Rotenberg	1993	143
17	Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. Journal of Clinical Oncology ·Christopher D. Myers,Michael R. Cooper,C.A. Stein,R. V. Larocca,McClellan M. Walther,Geoffrey R. Weiss,P L Choyke,Nancy A. Dawson,Seth M. Steinberg,Margaret Uhrich	1992	200
18	Effect of Evans Blue and Trypan Blue on Syncytia Formation and Infectivity of Human Immunodeficiency Virus Type I and Type II In Vitro AIDS Research and Human Retroviruses ·Ranajit Pal,Patricia Dzwill,George Hoke,Renato V. LaRocca,Charles E. Myers,M. G. Sarngadharan,C.A. Stein	1991	12
19	Genetic Changes in Human Adrenocortical Carcinomas JNCI Journal of the National Cancer Institute ·Tomohiro Yano,M. Linehan,Issei Mori,Michael I. Lerman,L.N. Daniel,C.A. Stein,Xu Gang,R. V. Larocca,B. Zbar	1989	96
20	Phosphoroselenoate oligodeoxynucleotides: synthesis, physico-chemical characterization, anti-sense inhibitory properties and anti-HIV activity Nucleic Acids Research ·Kazuyo Mori,Claudine Boiziau,C. Cazenave,Makoto Matsukura,C. Subasinghe,Jack S. Cohen,S Broder,Jean‐Jacques Toulmé,C.A. Stein	1989	58

About C.A. Stein

C.A. Stein is a scholar working on Virology, Molecular Biology, Toxicology, Immunology and Organic Chemistry, having authored 98 papers that have together received 7.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (29 papers), DNA and Nucleic Acid Chemistry (28 papers), Advanced biosensing and bioanalysis techniques (14 papers), Cell death mechanisms and regulation (11 papers), RNA and protein synthesis mechanisms (9 papers), HIV Research and Treatment (8 papers), CRISPR and Genetic Engineering (7 papers) and HIV/AIDS drug development and treatment (7 papers). The work is most often cited by research in Molecular Biology (5.7k citations), Virology (351 citations), Cancer Research (816 citations), Immunology (754 citations) and Oncology (859 citations). C.A. Stein has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Jack S. Cohen, Nathalie Dias, C. Subasinghe, Kazuo Shinozuka, Len Neckers, Charles E. Myers, S.L. Loke, R. V. Larocca, Kazuyo Mori and Mahito Nakanishi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research, Clinical Cancer Research, Nature Biotechnology and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact